View Item 

Show simple item record

Clinical pharmacist services within intensive care unit recovery clinics: An opinion of the critical care practice and research network of the American College of Clinical Pharmacy
dc.contributor.authorMohammad, Rima A.
dc.contributor.authorBetthauser, Kevin D.
dc.contributor.authorKorona, Rebecca Bookstaver
dc.contributor.authorCoe, Antoinette B.
dc.contributor.authorKolpek, Jimmi Hatton
dc.contributor.authorFritschle, Andrew C.
dc.contributor.authorJagow, Benjamin
dc.contributor.authorKenes, Michael
dc.contributor.authorMacTavish, Pamela
dc.contributor.authorSlampak‐cindric, Angela A.
dc.contributor.authorWhitten, Jessica A.
dc.contributor.authorJones, Carol
dc.contributor.authorSimonelli, Robert
dc.contributor.authorRowlands, Ian
dc.contributor.authorStollings, Joanna L.
dc.date.accessioned2020-12-02T14:37:54Z
dc.date.availableWITHHELD_12_MONTHS
dc.date.available2020-12-02T14:37:54Z
dc.date.issued2020-11
dc.identifier.citationMohammad, Rima A.; Betthauser, Kevin D.; Korona, Rebecca Bookstaver; Coe, Antoinette B.; Kolpek, Jimmi Hatton; Fritschle, Andrew C.; Jagow, Benjamin; Kenes, Michael; MacTavish, Pamela; Slampak‐cindric, Angela A. ; Whitten, Jessica A.; Jones, Carol; Simonelli, Robert; Rowlands, Ian; Stollings, Joanna L. (2020). "Clinical pharmacist services within intensive care unit recovery clinics: An opinion of the critical care practice and research network of the American College of Clinical Pharmacy." Journal of the American College of Clinical Pharmacy 3(7): 1369-1379.
dc.identifier.issn2574-9870
dc.identifier.issn2574-9870
dc.identifier.urihttps://hdl.handle.net/2027.42/163579
dc.description.abstractIntensive care unit recovery clinics (ICU- RCs) have been proposed as a potential mechanism to address the multifaceted unmet needs of intensive care unit (ICU) survivors and caregivers. The needs of this population include, but are not limited to, medication optimization, addressing physical function and psychological needs, coordination of care, and other interventions that may help in improving patient recovery and reducing the rate of preventable readmissions. The objective of this opinion paper is to identify and describe clinical pharmacy services for the management of ICU survivors and their caregivers in an ICU- RC. The goals are to guide the establishment and development of clinical pharmacist involvement in ICU- RCs and to highlight ICU recovery research and educational opportunities. Recommendations provided in this paper are based on the following: a review of published data on clinical pharmacist involvement in the ICU- RCs; a consensus of clinical pharmacists who provide direct patient care to ICU survivors and caregivers; and a review of published guidelines and literature focusing on the management of ICU survivors and caregivers. These recommendations define areas of clinical pharmacist involvement in ICU- RCs. Consequently, clinical pharmacists can promote education on Post Intensive Care Syndrome and Post Intensive Care Syndrome- Family; improve medication adherence; facilitate appropriate referrals to primary care providers and specialists; ensure comprehensive medication management and medication reconciliation; provide assessment of inappropriate and appropriate medications after hospitalization; address adverse drug events, medication errors, and drug interactions; promote preventive measures; and facilitate medication acquisition with the goal of improving patient outcomes and reducing health care system costs.
dc.publisherJohn Wiley & Sons, Inc.
dc.subject.othertransitions of care
dc.subject.othermanagement
dc.subject.otherintensive care
dc.subject.othercritical illness
dc.subject.othercomprehensive medication
dc.subject.otherpharmacy service
dc.titleClinical pharmacist services within intensive care unit recovery clinics: An opinion of the critical care practice and research network of the American College of Clinical Pharmacy
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPharmacy and Pharmacology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/163579/2/jac51311.pdfen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/163579/1/jac51311_am.pdfen_US
dc.identifier.doi10.1002/jac5.1311
dc.identifier.sourceJournal of the American College of Clinical Pharmacy
dc.identifier.citedreferenceEzeanolue E, Harriman K, Hunter P, Kroger A, Pellegrini C. General best practice guidelines for immunization. Best Practices Guidance of the Advisory Committee on Immunization Practices (ACIP). https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/index.html (accessed June 1, 2020).
dc.identifier.citedreferenceCoe AB, Bookstaver RE, Fritschle AC, et al. Pharmacists’ perceptions on their role, activities, facilitators, and barriers to practicing in a post- intensive care recovery clinic. Hospital Pharmacy. 2020; 55: 119 - 125. https://doi.org/10.1177/0018578718823740.
dc.identifier.citedreferenceStollings JL, Bloom SL, Wang L, Ely EW, Jackson JC, Sevin CM. Critical care pharmacists and medication management in an ICU recovery center. Ann Pharmacother. 2018; 52 ( 8 ): 713 - 723.
dc.identifier.citedreferenceAmerican College of Clinical Pharmacy. Standards of practice for clinical pharmacists. https://www.accp.com/docs/positions/guidelines/standardsofpractice.pdf (accessed June 1, 2020).
dc.identifier.citedreferenceMorandi A, Vasilevskis E, Pandharipande PP, et al. Inappropriate medication prescriptions in elderly adults surviving an intensive care unit hospitalization. J Am Geriatr Soc. 2013; 61 ( 7 ): 1128 - 1134.
dc.identifier.citedreferenceRunganga M, Peel NM, Hubbard RE. Multiple medication use in older patients in post- acute transitional care: a prospective cohort study. Clin Interven Aging. 2014; 9: 1453 - 1462.
dc.identifier.citedreferenceJasiak KD, Middleton EA, Camamo JM, Erstad BL, Snyder LS, Huckleberry YC. Evaluation of discontinuation of atypical antipsychotics prescribed for ICU delirium. J Pharm Pract. 2013; 26 ( 3 ): 253 - 256.
dc.identifier.citedreferenceShin S. Evaluation of costs accrued through inadvertent continuation of hospital- initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart review. Ther Clin Risk Manag. 2015; 11: 649 - 657.
dc.identifier.citedreferenceThomas L, Culley EJ, Gladowski P, Goff V, Fong J, Marche SM. Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization. J Manag Care Pharm. 2010; 16 ( 2 ): 122 - 129.
dc.identifier.citedreferenceTomichek JE, Stollings JL, Pandharipande PP, Chandrasekhar R, Ely EW, Girard TD. Antipsychotic prescribing patterns during and after critical illness: a prospective cohort study. Crit Care. 2016; 20 ( 1 ): 378.
dc.identifier.citedreferenceFeldman JD, Otting RI, Otting CM, Witry MJ. A community pharmacist- led service to facilitate care transitions and reduce hospital readmissions. J Am Pharm Assoc. 2018; 58 ( 1 ): 36 - 43.
dc.identifier.citedreferenceSalas CM, Miyares MA. Implementing a pharmacy resident run transition of care service for heart failure patients: Effect on readmission rates. Am J Health Syst Pharm. 2015; 71 ( 11 Suppl 1 ): S43 - S47.
dc.identifier.citedreferenceErku DA, Ayele AA, Mekuria AB, Belachew SA, Hailemeskel B, Tegegn HG. The impact of pharmacist- led medication therapy management on medication adherence in patients with type 2 diabetes mellitus: a randomized controlled study. Pharm Pract (Granada). 2017; 15 ( 3 ): 1026.
dc.identifier.citedreferenceLee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low- density lipoprotein cholesterol a randomized controlled trial. JAMA. 2006; 296 ( 21 ): 2563 - 2571. https://doi.org/10.1001/jama.296.21.joc60162.
dc.identifier.citedreferenceBell CM, Brener SS, Gunraj N, et al. Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases. JAMA. 2011; 306 ( 8 ): 840 - 847.
dc.identifier.citedreferenceBell CM, Rahimi- Darabad P, Orner AI. Discontinuity of chronic medications in patients discharged from the intensive care unit. J Gen Intern Med. 2006; 21: 937 - 941.
dc.identifier.citedreferenceKaramchandani K, Schoaps RS, Bonavia A, et al. Continuation of atypical antipsychotic medications in critically ill patients discharged from the hospital: a single- center retrospective analysis. Ther Adv Drug Saf. 2018; 10: 2042098618809933. https://doi.org/10.1177/2042098618809933 eCollection 2019.
dc.identifier.citedreferencePene F, Pickkers P, Hotchkiss RS. Is this critically ill patient immunocompromised? Intensive Care Med. 2016; 42: 1051 - 1054.
dc.identifier.citedreferenceKroger AT, Duchin J, Vázquez M. General best practice guidelines for immunization: best practices of the Advisory Committee on Immunization Practices (ACIP). http://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/downloads/general-recs.pdf (accessed June 1, 2020).
dc.identifier.citedreferenceReeder TA, Mutnick A. Pharmacist- versus physician- obtained medication histories. Am J Health Syst Pharm. 2008; 65: 857 - 860.
dc.identifier.citedreferenceHellström LM, Bondesson à , Höglund P, Eriksson T. Errors in medication history at hospital admission: prevalence and predicting factors. BMC Clin Pharmacol. 2012; 12: 9.
dc.identifier.citedreferenceMcCullough MB, Petrakis BA, Gillespie C, et al. Knowing the patient: a qualitative study on care- taking and the clinical pharmacist- patient relationship. Res Social Adm Pharm. 2016; 12 ( 1 ): 78 - 87.
dc.identifier.citedreferencePun BT, Balas MC, Barnes- Daly MA, et al. Caring for Critically Ill Patients With the ABCDEF Bundle: Results of the ICU Liberation Collaborative in Over 15,000 Adults. Crit Care Med. 2019; 47 ( 1 ): 3 - 14. https://doi.org/10.1097/CCM.0000000000003482.
dc.identifier.citedreferenceMarshall J, Finn CA, Theodore AC. Impact of a clinical pharmacist- enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay. Crit Care Med. 2008; 36 ( 2 ): 427 - 433.
dc.identifier.citedreferenceStollings JL, Foss JJ, Ely EW, et al. Pharmacist leadership in ICU quality improvement: coordinating spontaneous awakening and breathing trials. Ann Pharmacother. 2015; 49 ( 8 ): 883 - 891.
dc.identifier.citedreferenceMacLaren R, Plamondon JM, Ramsay KB, Rocker GM, Patrick WD, Hall RI. A prospective evaluation of empiric versus protocol- based sedation and analgesia. Pharmacotherapy. 2000; 20 ( 6 ): 662 - 672.
dc.identifier.citedreferenceLouzon P, Jennings H, Ali M, Kraisinger M. Impact of pharmacist management of pain, agitation, and delirium in the intensive care unit through participation in multidisciplinary bundle rounds. Am J Health Syst Pharm. 2017; 74 ( 4 ): 253 - 262.
dc.identifier.citedreferenceAmerican Pharmacist Association (APhA). Pharmacists can help with meaningful use. https://www.pharmacist.com/pharmacists-can-help-meaningful-use (accessed June 1, 2020).
dc.identifier.citedreferencePestka DL, Sorge LA, McClurg MR, Sorenson TD. The philosophy of practice for comprehensive medication management: evaluating its meaning and application by practitioners. Pharmacotherapy. 2018; 38 ( 1 ): 69 - 79.
dc.identifier.citedreferenceAmerican College of Clinical Pharmacy. Comprehensive Medication Management in Team- Based Care. https://www.accp.com/docs/positions/misc/CMM%20Brief.pdf (accessed July 1, 2020).
dc.identifier.citedreferenceSmith MA. Implementing primary care pharmacist services: Go upstream in the world of value- based payment models. Res Social Adm Pharm. 2017; 13 ( 5 ): 892 - 895.
dc.identifier.citedreferenceSowell AJ, Pherson EC, Almuete VI, et al. Expansion of inpatient clinical pharmacy services through reallocation of pharmacists. Am J Health Syst Pharm. 2017; 74 ( 21 ): 1806 - 1813.
dc.identifier.citedreferenceKosinski S, Mohammad RA, Pitcher M, et al. What Is Post- Intensive Care Syndrome (PICS)? Am J Respir Crit Care Med. 2020; 201 ( 8 ): P15 - P16.
dc.identifier.citedreferencePorter ME, Thomas HL. The Strategy That Will Fix Health Care. Harv Bus Rev. 2013; 91 ( 10 ): 50 - 70.
dc.identifier.citedreferenceBoard of Pharmacy Specialties. Critical Care Pharmacy: https://www.bpsweb.org/bps-specialties/critical-care-pharmacy/ (accessed July 13, 2020).
dc.identifier.citedreferenceBarrett NA, Jones A, Whiteley C, Yassin S, McKenzie CA. Management of long- term hypothyroidism: a potential marker of quality of medicines reconciliation in the intensive care unit. Int J Pharm Pract. 2012; 20 ( 5 ): 303 - 306. https://doi.org/10.1111/j.2042-7174.2012.00205.x Epub May 2, 2012.
dc.identifier.citedreferenceSevin CM, Bloom SL, Jackson JC, Wang L, Ely EW, Stollings JL. Comprehensive care of ICU survivors: Development and implementation of an ICU recovery center. J Crit Care. 2018; 46: 141 - 148. https://doi.org/10.1016/j.jcrc.2018.02.011.
dc.identifier.citedreferenceSociety of Critical Care Medicine Critical Care Statistics. https://www.sccm.org/Communications/Critical-Care-Statistics (accessed August 1, 2019).
dc.identifier.citedreferenceHirshberg EL, Wilson EL, Stanfield V, et al. Impact of critical illness on resource utilization: a comparison of use in the year before and after ICU admission. Crit Care Med. 2019; 47 ( 11 ): 1497 - 1504.
dc.identifier.citedreferenceRawal G, Yadav S, Kumer R. Post- intensive care syndrome: an overview. J Transl Int Med. 2017; 5 ( 2 ): 90 - 92.
dc.identifier.citedreferenceNeedham DM, Davidson J, Cohen H, et al. Improving long- term outcomes after discharge from intensive care unit: Report from a stakeholders’ conference. Crit Care Med. 2012; 40: 502 - 509.
dc.identifier.citedreferenceSociety of Critical Care Medicine. Post- Intensive Care Syndrome. https://www.sccm.org/MyICUCare/THRIVE/Post-intensive-Care-Syndrome (accessed August 1, 2019).
dc.identifier.citedreferenceEijsbroek H, Howell DC, Smith F, Shulman R. Medication issues experienced by patients and caregivers after discharge from the intensive care unit. J Crit Care. 2013; 28 ( 1 ): 46 - 50. https://doi.org/10.1016/j.jcrc.2012.06.002 Epub 2012 Jul 24.
dc.identifier.citedreferenceHeidelbaugh JJ, Kim AH, Chang R, Walker PC. Overutilization of proton- pump inhibitors: what the clinician needs to know. Therp Adv Gastroenterol. 2012; 5 ( 4 ): 219 - 232.
dc.identifier.citedreferenceTully AP, Hammond DA, Li C, Jarrell AS, Kruer RM. Evaluation of Medication Errors at the Transition of Care From an ICU to Non- ICU Location. Crit Care Med. 2019; 47 ( 4 ): 543 - 549.
dc.identifier.citedreferencePavlov A, Muravyev R, Amoateng- Adjepong Y, Manthous CA. Inappropriate discharge on bronchodilators and acid- blocking medications after ICU admission: importance of medication reconciliation. Respir Care. 2014; 59 ( 10 ): 1524 - 1529.
dc.identifier.citedreferenceKram BL, Schultheis JM, Kram SJ, Cox CE. A pharmacy- based electronic handoff tool to reduce discharge prescribing of atypical antipsychotics initiated in the intensive care unit: a quality improvement initiative. J Pharm Pract. 2018:897190018761412; 32: 434 - 441. https://doi.org/10.1177/0897190018761412. [Epub ahead of print.
dc.identifier.citedreferenceMasood U, Sharma A, Bhatti Z, et al. A successful pharmacist- based quality initiative to reduce inappropriate stress ulcer prophylaxis use in an academic medical intensive care unit. Inquiry. 2018; 55: 46958018759116. https://doi.org/10.1177/0046958018759116.
dc.identifier.citedreferenceCampbell AJ, Bloomfield R, Noble DW. An observational study of changes to long term medication after admission to an intensive care unit. Anaesthesia. 2006; 61: 1087 - 1092.
dc.identifier.citedreferenceAssociation of American Medical Colleges (AAMC) News. Looming Doctor Shortage Could Impact Patient Care. https://www.aamc.org/news- insights/looming- doctor- shortage- could- impact- patient- care#:~:text=A%20rapidly%20growing%20and%20aging,data%20released%20by%20the%20AAMC.&text=%E2%80%9CIt%20is%20particularly%20serious%20for,our%20aging%20population%20will%20need.%E2%80%9D (accessed July 10, 2020).
dc.identifier.citedreferenceSociety of Critical Care Medicine. THRIVE Collaborative. https://www.sccm.org/Research/Quality/THRIVE (accessed July 13, 2020).
dc.identifier.citedreferenceCritical and Acute Illness Recovery Organization (CAIRO). https://sites.google.com/umich.edu/cairo (accessed June 1, 2020).
dc.identifier.citedreferenceBloom SL, Stollings JL, Kirkpatrick O, et al. Randomized clinical trial of an ICU recovery pilot program for survivors of critical illness. Crit Care Med. 2019; 47: 1337 - 1345. https://doi.org/10.1097/CCM.0000000000003909. [Epub ahead of print.
dc.identifier.citedreferenceStollings JL, Bloom SL, Sevin CM. Reply: Critical care pharmacists and medication management in an ICU recovery center. Ann Pharmacother. 2019; 53 ( 1 ): 106.
dc.identifier.citedreferenceBrilli RJ, Spevetz A, Branson RD, et al. Critical care delivery in the intensive care unit: defining clinical roles and the best practice model. Crit Care Med. 2001; 29 ( 10 ): 2007 - 2019.
dc.identifier.citedreferenceHaupt MT, Bekes CE, Brill RJ, et al. Guidelines on critical care services and personnel: Recommendations based on a system of categorization of three levels of care. Crit Care Med. 2003; 31 ( 11 ): 2677 - 2683.
dc.identifier.citedreferenceHuggins EL, Bloom SL, Stollings JL, Camp M, Sevin CM, Jackson JC. A clinic model: post- intensive care syndrome and post- intensive care syndrome- family. AACN Adv Crit Care. 2016; 27 ( 2 ): 204 - 211.
dc.identifier.citedreferenceJones LK, Greskovic G, Grassi DM, et al. Medication therapy disease management: Geisinger’s approach to population health management. Am J Health Syst Pharm. 2017; 74 ( 18 ): 1422 - 1435.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jac51311_am.pdf
Size:
388.6KB
Format:
PDF
View/Open
Name:
jac51311.pdf
Size:
858.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.